UNC Eshelman School of Pharmacy Continues Unrivaled Dominance in Research Funding, Secures Top National Rank Yet Again!

CHAPEL HILL, NC — The University of North Carolina at Chapel Hill's Eshelman School of Pharmacy has once again solidified its reputation as a national powerhouse in pharmaceutical innovation, proudly retaining its number one ranking for external research funding among all schools of pharmacy across the United States.

This remarkable achievement underscores a sustained commitment to groundbreaking scientific inquiry and an unparalleled ability to attract critical support for transformative health solutions.

For yet another year, the Eshelman School has demonstrated its exceptional prowess in securing competitive grants and contracts from a diverse array of sources, including the National Institutes of Health (NIH), other federal agencies, leading foundations, and strategic industry partners.

This consistent influx of funding fuels a vast portfolio of research, ranging from novel drug discovery and development to advanced pharmaceutical outcomes and patient care strategies, directly addressing some of humanity's most pressing health challenges.

Dean Angela Kashuba expressed immense pride in the faculty, staff, and students whose relentless dedication drives this success.

"Retaining the top national rank for external research funding is a profound testament to the caliber of our researchers and the visionary scope of their work," she stated. "It reflects our collective commitment to pushing the boundaries of pharmaceutical science, translating discoveries into tangible health benefits, and training the next generation of leaders in pharmacy and research.

This funding isn't just about numbers; it's about impact – on patients, on public health, and on the future of medicine."

The significant external investment in Eshelman's research enterprise empowers scientists to explore uncharted territories in areas like precision medicine, infectious disease, oncology, neurodegeneration, and health disparities.

It provides the resources necessary for state-of-the-art laboratories, cutting-edge technology, and the recruitment of world-class talent, fostering an environment where innovation flourishes and bold ideas are brought to life.

This continued leadership in research funding not only elevates the Eshelman School of Pharmacy but also reinforces UNC-Chapel Hill's standing as a premier global research institution.

It positions the university at the forefront of pharmaceutical advancements, ensuring that breakthroughs developed on campus have the potential to reach patients worldwide and contribute significantly to global health and economic development.

As the Eshelman School looks to the future, its unwavering dedication to research excellence, collaborative spirit, and strategic pursuit of external support will continue to drive its mission: to revolutionize education and health care through innovation in pharmacy practice, education, and research.